Clinical value of N-myc oncogene amplification in 52 patients with neuroblastoma included in recent therapeutic protocols
- 1 November 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (11), 1607-1612
- https://doi.org/10.1016/0277-5379(89)90305-2
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantationBritish Journal of Cancer, 1989
- Sequential cisplatin/VM-26 and vincristine/cyclophosphamide/doxorubicin in metastatic neuroblastoma: an effective alternating non-cross-resistant regimen?Journal of Clinical Oncology, 1987
- A phase II study of high-dose cisplatin and VP-16 in neuroblastoma: a report from the Société Française d'Oncologie Pédiatrique.Journal of Clinical Oncology, 1987
- High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age.Journal of Clinical Oncology, 1987
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- Alkaline transfer of DNA to plastic membraneBiochemical and Biophysical Research Communications, 1984
- Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease StageScience, 1984
- A technique for radiolabeling DNA restriction endonuclease fragments to high specific activityAnalytical Biochemistry, 1984
- Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumourNature, 1983
- USE OF PANELS OF MONOCLONAL ANTIBODIES IN THE DIFFERENTIAL DIAGNOSIS OF NEUROBLASTOMA AND LYMPHOBLASTIC DISORDERSThe Lancet, 1983